Phoenix Venture Partners

Phoenix Venture Partners LLC is a venture capital firm based in San Mateo, California, with additional offices in Singapore and Cambridge, Massachusetts. Established in 2010, the firm specializes in early-stage investments, focusing on technologies and advanced materials across various sectors. Its investment areas include novel materials, optics, energy generation, healthcare, consumer electronics, and the Internet of Things, among others. Phoenix Venture Partners aims to partner with entrepreneurs to commercialize innovative materials science solutions and provides support in business development, customer partnerships, and operational strategies. The firm primarily invests in North America but also extends its activities to Europe, Asia, Central America, Mexico, and the Caribbean.

John T. Chen

Managing General Partner

Zach Jonasson

Co-Founder and Managing General Partner

Nobi Kambe

Co-Founder and Managing General Partner

Avinash Kant Ph.D

Partner

David Soane

Co-Founder and Special Partner

Jennifer Wang

CFO

35 past transactions

Biotia

Series A in 2022
Biotia, Inc. is a health technology company based in New York, founded in 2016. The company specializes in developing software that utilizes DNA sequencing and artificial intelligence to identify and mitigate pathogens and antimicrobial threats before they can cause illness. By leveraging next-generation sequencing and advanced software solutions, Biotia enables clinicians and researchers to enhance patient treatment and improve health outcomes through rapid precision in infectious disease discovery.

Autonomic Materials

Venture Round in 2022
Autonomic Materials, Inc. specializes in the design, manufacturing, and marketing of self-healing solutions specifically tailored for the coatings industry. The company offers a range of microencapsulated additives, including dual capsule systems utilizing reactive silicone polymers and single capsule systems that promote the curing of epoxy resin and facilitate cross-linking in functionalized alkyd resins. These innovative products provide enhanced protection for various substrates, including metals, wood, concrete, plastics, and composites. Applications of Autonomic Materials' solutions span diverse sectors such as alternative energy, industrial maintenance, military equipment, infrastructure, and consumer paints. Founded in 2005 and headquartered in Champaign, Illinois, the company aims to improve the durability and longevity of materials through its advanced self-healing technologies.

Eclipse Bioinnovations

Series A in 2022
Eclipse Bioinnovations, founded in 2017, specializes in RNA Next-Generation Sequencing (NGS) technologies developed from research in Professor Gene Yeo's laboratory at UC San Diego. The company focuses on advancing RNA medicines through its Eclipse-Seq platform, which aims to enhance the safety and efficacy of these treatments. One of its key innovations is eCLIP, a unique and efficient technology for identifying RNA binding protein partners and mapping genes. Eclipse offers eCLIP both as a service and a kit, catering to biopharma companies and academic researchers. The technology is adaptable for various RNA types, including siRNA and miRNA, assisting scientists in identifying RNA binding protein targets, thereby facilitating research and the development of new drugs to address a wide range of diseases.

InVivo AI

Seed Round in 2021
InVivo AI is a Montreal-based company founded in 2017 that specializes in using artificial intelligence to enhance pharmaceutical research and development. The company primarily focuses on preclinical toxicology, aiming to improve the efficiency and effectiveness of drug development processes. By leveraging advanced AI technologies, InVivo AI seeks to transform traditional methodologies in the pharmaceutical industry, ultimately contributing to faster and more reliable outcomes in drug safety assessments.

Xandar Kardian

Series A in 2021
Xandar Kardian provides commercially deployed 99.9% 'true' presence detection and people (occupancy) count solutions for smart building applications. It's patented and proprietary occupancy count system is the world's first and only commercial grade system that is able to count from any open space (virtual zones), making foot traffic counting possible in areas that was not possible with traditional cameras. Using micro-vibration patterns emitted from the body (chest movement from breathing, heart beat frequency from the heart (BPM) movement inside the body), XK is able to obtain 95% repetitive accurate RHR and RR measurements continuously. Occupant wellness - either in an office space, factory, hospital, nursing home or residential homes is now possible continuously, autonomously and without using any cameras or wearable devices.

FibreCoat

Venture Round in 2021
FibreCoat GmbH produces thermoplastic-coated glass fibres for use in fibre composites on rented glass fibre drawing machines. Direct coating enables new process steps, lower costs and cycle times while at the same time improving technical specifications. The target markets are the automotive and consumer sectors.

Inkbit

Series B in 2021
Inkbit Corporation is a Medford, Massachusetts-based company that specializes in the research, development, and manufacturing of 3D printers. Founded in 2017, Inkbit focuses on creating a next-generation additive manufacturing platform that integrates machine learning and artificial intelligence with material jetting and machine vision. The company leverages the expertise of MIT-trained scientists and engineers in industrial systems, design software, and material science to advance opportunities in mass-market additive manufacturing. Through its innovative approach, Inkbit aims to enhance the capabilities and applications of 3D printing technology.

FIGUR8

Series A in 2021
FIGUR8, Inc. is a Boston-based company established in 2016 that specializes in manufacturing wearable sensors designed to measure body movement as a biomarker for musculoskeletal-related conditions. The company also offers a platform that tracks and analyzes musculoskeletal health data, aiming to provide insights into human movement. Founded by a team of engineers, researchers, and designers with backgrounds in wearable computing, digital health, and sports science, FIGUR8 focuses on making advanced movement analysis accessible to a broader audience, moving beyond the elite users to everyday individuals.

Green Theme Technologies

Venture Round in 2021
Green Theme Technologies Inc develops chemical technology for finishing of textiles and nonwovens. The company was founded in 2012 and is based in Albuquerque, New Mexico.

L7 Informatics

Series B in 2021
L7 Informatics provides a workflow management software platform for companies using data-intensive scientific techniques. Advances in next-generation sequencing (NGS) are enabling rapid detection and diagnosis of genetic diseases. It has developed the Enterprise Sequencing Platform (ESP) to accelerate clinical adoption of sequencing and provide a platform for clinicians to easily track, manage, and interpret patient data. It is the first software designed from the ground-up that fully integrates all the requisite components of NGS data flow management, analysis, and reporting, with auditing capability. It was founded in 2012 and is headquartered in Austin, Texas.

Absci

Series E in 2020
AbSci, LLC is a biotechnology company based in Portland, Oregon, specializing in protein production technologies for the biopharmaceutical industry. Founded in 2011, AbSci has developed SoluPro, an innovative expression system utilizing genetically engineered E. coli to facilitate the scalable and cost-effective production of antibodies, antibody fragments, and other soluble recombinant proteins. This technology significantly lowers production costs for both novel and existing biologics, enhancing the efficiency of drug discovery and manufacturing processes. AbSci's therapeutic proteins and antibodies play vital roles in treatments for cancer, hormone-related conditions, autoimmune diseases, and blood disorders. The company's approach integrates biologic drug discovery with cell line development, positioning it as a leader in the advancement of next-generation therapeutics.

WaveFront Dynamics

Series A in 2020
WaveFront Dynamics is a medical device company with innovative wavefront diagnostic technology for use in the vision care industry.

Micropore

Series C in 2020
Micropore manufactures reactive plastics which incorporate various powders into a molded matrix. The company's first product uses a CO2 adsorbent powder which is formed into a cartridge to create a revolutionary CO2 adsorbent system used in rebreathing and life support applications. The patented technology is the first major advance in CO2 adsorbent technology in over 100 years, providing superior performance advantages over existing granular adsorbents. It was founded in March of 1997 and is based in Elkton, Maryland.

Crop Enhancement

Series B in 2020
Crop Enhancement LLC, an early stage specialty materials company, develops anchoring and controlled-release formulation technologies for agricultural chemicals. The company’s formulation technologies enable release of chemical agents, such as pesticides, herbicides, and fertilizers into target microenvironments. Crop Enhancement LLC was founded in 2011 and is based in San Jose, California.

Absci

Series D in 2020
AbSci, LLC is a biotechnology company based in Portland, Oregon, specializing in protein production technologies for the biopharmaceutical industry. Founded in 2011, AbSci has developed SoluPro, an innovative expression system utilizing genetically engineered E. coli to facilitate the scalable and cost-effective production of antibodies, antibody fragments, and other soluble recombinant proteins. This technology significantly lowers production costs for both novel and existing biologics, enhancing the efficiency of drug discovery and manufacturing processes. AbSci's therapeutic proteins and antibodies play vital roles in treatments for cancer, hormone-related conditions, autoimmune diseases, and blood disorders. The company's approach integrates biologic drug discovery with cell line development, positioning it as a leader in the advancement of next-generation therapeutics.
BroadSpot Imaging Corporation is developing a suite of diagnostic medical devices for eye care. They leverage advanced imaging technologies and small-scale, cloud-connected electronics to replace bulky, expensive diagnostic instruments with cost-effective handheld instruments and a series of valuable services. their technologies will fundamentally improve how eye care is delivered worldwide: eye doctors can see patients more efficiently, for less money, and more patients will gain access to high quality diagnostics as the population ages.

Absci

Series C in 2018
AbSci, LLC is a biotechnology company based in Portland, Oregon, specializing in protein production technologies for the biopharmaceutical industry. Founded in 2011, AbSci has developed SoluPro, an innovative expression system utilizing genetically engineered E. coli to facilitate the scalable and cost-effective production of antibodies, antibody fragments, and other soluble recombinant proteins. This technology significantly lowers production costs for both novel and existing biologics, enhancing the efficiency of drug discovery and manufacturing processes. AbSci's therapeutic proteins and antibodies play vital roles in treatments for cancer, hormone-related conditions, autoimmune diseases, and blood disorders. The company's approach integrates biologic drug discovery with cell line development, positioning it as a leader in the advancement of next-generation therapeutics.

Comera Life Sciences

Series A in 2018
Comera Life Sciences, formerly known as ReForm Biologics, is a biotechnology company focused on developing advanced formulation technologies for biotherapeutics. Founded in 2014 and based in Woburn, Massachusetts, the company specializes in creating patented, FDA-friendly excipients that enhance the stability and administration of therapeutic biologics. Comera's proprietary platforms enable pharmaceutical companies to produce life-saving medications that are easier to administer, less immunogenic, and more efficient to manufacture, ultimately improving treatment options for fragile patients.

NBD Nanotechnologies

Series B in 2017
NBD Nanotechnologies, Inc. specializes in the manufacture of surface wettability coatings and additives aimed at enhancing the properties of various materials. The company's diverse product portfolio includes offerings such as RepelShell, RepelFlex Antimicrobial, RepelFlex Soft-Touch, NanoGlue, RepelFlex Hard-Coat, Invisiprint, and RepelFlex Leather. These products are designed to modify surface wetting characteristics for applications in glass and plastic, providing benefits such as improved heat transfer through condensation, fog capture and de-misting, and anti-scaling performance. Founded in 2012, NBD Nanotechnologies is headquartered in Lexington, Massachusetts.

Furcifer Inc.

Series A in 2017
​Furcifer Inc. is a venture-backed Silicon Valley startup that focuses on developing and manufacturing of next-generation electrochromic films (smart films), with a broad range of applications that include automotive, real estate and electronic display markets.we
BroadSpot Imaging Corporation is developing a suite of diagnostic medical devices for eye care. They leverage advanced imaging technologies and small-scale, cloud-connected electronics to replace bulky, expensive diagnostic instruments with cost-effective handheld instruments and a series of valuable services. their technologies will fundamentally improve how eye care is delivered worldwide: eye doctors can see patients more efficiently, for less money, and more patients will gain access to high quality diagnostics as the population ages.

Absci

Series B in 2017
AbSci, LLC is a biotechnology company based in Portland, Oregon, specializing in protein production technologies for the biopharmaceutical industry. Founded in 2011, AbSci has developed SoluPro, an innovative expression system utilizing genetically engineered E. coli to facilitate the scalable and cost-effective production of antibodies, antibody fragments, and other soluble recombinant proteins. This technology significantly lowers production costs for both novel and existing biologics, enhancing the efficiency of drug discovery and manufacturing processes. AbSci's therapeutic proteins and antibodies play vital roles in treatments for cancer, hormone-related conditions, autoimmune diseases, and blood disorders. The company's approach integrates biologic drug discovery with cell line development, positioning it as a leader in the advancement of next-generation therapeutics.

C3Nano

Series D in 2017
C3Nano is the developer of the solution-based, transparent conductive inks and films as direct replacements for indium tin oxide (ITO). C3Nano is the performance leader in Transparent Conductor Films (TCFs) and Activegrid silver nanowire (AgNW) solution-based inks for the touch sensor and display industry. They have raised $37 million in funding to date, which has enabled the company to quickly achieve best in class ink formulations and expanded production capabilities. C3Nano is headquartered in Silicon Valley with an industry-leading manufacturing base in Korea. Founded in 2010, it is headquartered in Hayward, California.

Crop Enhancement

Series B in 2016
Crop Enhancement LLC, an early stage specialty materials company, develops anchoring and controlled-release formulation technologies for agricultural chemicals. The company’s formulation technologies enable release of chemical agents, such as pesticides, herbicides, and fertilizers into target microenvironments. Crop Enhancement LLC was founded in 2011 and is based in San Jose, California.

Nohms Technologies

Series B in 2016
NOHMs Technologies is developing materials and manufacturing processes for advanced lithium-ion battery electrolyte that enables twice the energy and runtime for half the cost in consumer electronics and electric vehicles via sales and licensing business model. The company's NanoLyte Electrolyte solutions contain new functional ionic liquid materials that significantly improve the performance and safety of next-generation lithium-ion batteries. NOHMs Technologies was founded in 2011 and is headquartered in Rochester, New York, United States.

Amber Molecular

Series A in 2016
Amber Molecular Inc. develops materials for novel fluorescent organic light-emitting diodes (OLED) emitters. The company was founded in 2017 and is based in Toronto, Canada.

Absci

Series A in 2016
AbSci, LLC is a biotechnology company based in Portland, Oregon, specializing in protein production technologies for the biopharmaceutical industry. Founded in 2011, AbSci has developed SoluPro, an innovative expression system utilizing genetically engineered E. coli to facilitate the scalable and cost-effective production of antibodies, antibody fragments, and other soluble recombinant proteins. This technology significantly lowers production costs for both novel and existing biologics, enhancing the efficiency of drug discovery and manufacturing processes. AbSci's therapeutic proteins and antibodies play vital roles in treatments for cancer, hormone-related conditions, autoimmune diseases, and blood disorders. The company's approach integrates biologic drug discovery with cell line development, positioning it as a leader in the advancement of next-generation therapeutics.
Sentinel Monitoring Systems is at-line and in-line QC systems for ultra-rapid detection of microbial contamination. The Sentinel Online Monitor is a multivariate spectroscopic analyzer for real-time monitoring of bioburden and other target analytes. The Sentinel Sample Collector automatically collects excursion samples identified by online monitors and/or periodic samples during production runs. Other Sentinel products currently in development include automated online endotoxin monitoring and near real-time at-line systems for bioburden and specific organisms. It was founded in 2015 and is based in Tucson, Arizona.

C3Nano

Series C in 2014
C3Nano is the developer of the solution-based, transparent conductive inks and films as direct replacements for indium tin oxide (ITO). C3Nano is the performance leader in Transparent Conductor Films (TCFs) and Activegrid silver nanowire (AgNW) solution-based inks for the touch sensor and display industry. They have raised $37 million in funding to date, which has enabled the company to quickly achieve best in class ink formulations and expanded production capabilities. C3Nano is headquartered in Silicon Valley with an industry-leading manufacturing base in Korea. Founded in 2010, it is headquartered in Hayward, California.

NBD Nanotechnologies

Series A in 2014
NBD Nanotechnologies, Inc. specializes in the manufacture of surface wettability coatings and additives aimed at enhancing the properties of various materials. The company's diverse product portfolio includes offerings such as RepelShell, RepelFlex Antimicrobial, RepelFlex Soft-Touch, NanoGlue, RepelFlex Hard-Coat, Invisiprint, and RepelFlex Leather. These products are designed to modify surface wetting characteristics for applications in glass and plastic, providing benefits such as improved heat transfer through condensation, fog capture and de-misting, and anti-scaling performance. Founded in 2012, NBD Nanotechnologies is headquartered in Lexington, Massachusetts.

Imprint Energy

Series A in 2014
Imprint Energy, Inc. specializes in developing and commercializing innovative zinc-based rechargeable battery technology. The company's flagship product, ZincPoly, overcomes traditional limitations associated with zinc batteries, enabling the creation of rechargeable solutions suitable for a variety of applications. Targeting the small portable electronics market, Imprint Energy focuses on sectors such as mobile accessories, wearable technology, and medical devices. The company's technology promises to deliver performance comparable to lithium batteries while significantly reducing costs and eliminating safety concerns associated with traditional battery designs. Founded in 2010 and headquartered in Alameda, California, Imprint Energy aims to meet the evolving energy demands of contemporary and future electronic devices.

Autonomic Materials

Series B in 2012
Autonomic Materials, Inc. specializes in the design, manufacturing, and marketing of self-healing solutions specifically tailored for the coatings industry. The company offers a range of microencapsulated additives, including dual capsule systems utilizing reactive silicone polymers and single capsule systems that promote the curing of epoxy resin and facilitate cross-linking in functionalized alkyd resins. These innovative products provide enhanced protection for various substrates, including metals, wood, concrete, plastics, and composites. Applications of Autonomic Materials' solutions span diverse sectors such as alternative energy, industrial maintenance, military equipment, infrastructure, and consumer paints. Founded in 2005 and headquartered in Champaign, Illinois, the company aims to improve the durability and longevity of materials through its advanced self-healing technologies.

Vixar

Series B in 2012
Vixar Inc. manufactures short wavelength vertical cavity surface emitting laser (VCSEL) and LED based optical components and subassemblies for sensor and device applications. It serves biomedical, industrial, office product, military, automotive, and consumer industries. The company was founded in 2005 and is based in Plymouth, Minnesota. As of July 2, 2018, Vixar Inc. operates as a subsidiary of OSRAM Licht AG.

C3Nano

Series B in 2012
C3Nano is the developer of the solution-based, transparent conductive inks and films as direct replacements for indium tin oxide (ITO). C3Nano is the performance leader in Transparent Conductor Films (TCFs) and Activegrid silver nanowire (AgNW) solution-based inks for the touch sensor and display industry. They have raised $37 million in funding to date, which has enabled the company to quickly achieve best in class ink formulations and expanded production capabilities. C3Nano is headquartered in Silicon Valley with an industry-leading manufacturing base in Korea. Founded in 2010, it is headquartered in Hayward, California.